study of ribociclib and pdr001 in hr metastatic breast cancer
Published 5 years ago • 3.6K plays • Length 7:23Download video MP4
Download video MP3
Similar videos
-
49:09
metastatic breast cancer forum 2018: her2-positive breast cancer | dana-farber cancer institute
-
8:09
what is metastatic breast cancer? | dana-farber cancer institute
-
1:00:06
metastatic breast cancer forum 2018: er breast cancer | dana-farber cancer institute
-
6:29
study of palbociclib after cdk & endocrine therapy in er /her2- metastatic breast cancer
-
4:59
study of saci-io for hormone receptor positive metastatic breast cancer
-
39:15
metastatic breast cancer forum 2018: clinical trials 101 | dana-farber cancer institute
-
33:41
clinical trials for metastatic breast cancer: what you should know | dana-farber cancer institute
-
23:00
what's new in metastatic breast cancer research | dana-farber cancer institute
-
1:24
encouraging findings with ribociclib in hr breast cancer
-
5:21
study of neratinib for patients with her2-positive breast cancer with brain metastases
-
2:46
program for patients with breast cancer brain metastases | dana-farber cancer institute
-
2:33
breast cancer: young mother embraces life | dana-farber cancer institute
-
1:18
esmo22: breast cancer research by sara tolaney, md (tropics) | dana-farber cancer institute
-
0:57
evaluating the benefits of selective cdk4 inhibition in hr /her2- breast cancer
-
1:17
study: breast cancer risk and mastectomies | dana-farber cancer institute
-
4:27
study of immunotherapy combinations for patients with her2-positive metastatic breast cancer
-
56:00
metastatic breast cancer forum 2018: triple negative breast cancer | dana-farber cancer institute
-
1:58
study: oncologists and cancer gene testing | dana-farber cancer institute
-
2:11
heather a. parsons, md, mph, on breast cancer treatment | dana-farber cancer institute